BAL PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Bal Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.57₹ 1.79
As on Feb 9, 2026, 4:01 PM IST
Bal Pharma Price Performance
Today's LowToday's High
₹69.55₹71.34
₹71.34
52 Weeks' Low52 Weeks' High
₹64.00₹128.86
₹71.34
Open Price
₹69.55
Prev. Close
₹69.55
Volume
76
Over the last 5 years, the share price of Bal Pharma has gained 3.87% CAGR. Over the past year, the corresponding return has been -35.47%.
Bal Pharma’s current P/E of 16.64x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Bal Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bal Pharma | 6.24 | -3.12 | -12.87 | -20.81 | -35.47 | -5.00 | 3.87 |
| Sun Pharmaceutical Industries | 6.87 | -4.37 | 0.70 | 6.63 | -2.57 | 19.23 | 21.85 |
| Divi's Laboratories | 1.03 | -7.91 | -8.11 | -0.27 | -0.39 | 30.55 | 10.09 |
| Torrent Pharmaceuticals | 0.97 | -2.28 | 11.69 | 11.15 | 22.66 | 37.59 | 23.72 |
| Cipla | 1.40 | -8.51 | -10.77 | -9.99 | -8.82 | 9.19 | 9.63 |
| Dr. Reddy's Laboratories | 4.42 | 2.39 | 5.56 | 5.96 | 2.55 | 12.72 | 5.55 |
| Lupin | 2.76 | -0.14 | 12.12 | 13.57 | 0.50 | 43.25 | 15.62 |
| Zydus Lifesciences | 3.99 | -0.72 | -2.46 | -2.62 | -7.38 | 24.29 | 14.23 |
| Mankind Pharma | -1.81 | -9.74 | -7.81 | -17.92 | -17.15 | 13.58 | 7.94 |
| Aurobindo Pharma | -0.91 | -2.76 | 6.97 | 12.33 | 0.80 | 42.10 | 4.65 |
| Alkem Laboratories | 1.07 | -0.98 | 1.04 | 17.54 | 11.22 | 23.21 | 14.59 |
| Biocon | 2.01 | -3.43 | -1.64 | 2.55 | -3.23 | 16.30 | -1.78 |
| Abbott India | -0.81 | -3.66 | -4.69 | -16.22 | -7.87 | 9.41 | 13.62 |
| Glenmark Pharmaceuticals | -2.23 | -6.68 | 8.65 | -4.43 | 28.04 | 71.29 | 31.42 |
| Laurus Labs | 2.09 | -12.70 | 0.28 | 17.55 | 53.63 | 43.95 | 22.52 |
| GlaxoSmithKline Pharmaceuticals | 4.74 | 2.16 | -3.07 | -6.27 | 13.91 | 26.53 | 11.47 |
| Anthem Biosciences | 12.46 | 2.67 | -3.42 | -10.30 | -7.83 | -2.68 | -1.62 |
| Ipca Laboratories | -0.97 | -3.89 | 10.08 | 4.61 | -3.40 | 19.14 | 8.42 |
| Ajanta Pharma | 2.52 | 0.03 | 13.00 | 9.11 | 6.12 | 33.94 | 18.79 |
| Gland Pharma | 2.15 | 10.35 | 1.32 | -3.67 | 24.33 | 12.94 | -4.08 |
Over the last one year, Bal Pharma has declined 35.47% compared to peers like Sun Pharmaceutical Industries (-2.57%), Divi's Laboratories (-0.39%), Torrent Pharmaceuticals (22.66%). From a 5 year perspective, Bal Pharma has underperformed peers relative to Sun Pharmaceutical Industries (21.85%) and Divi's Laboratories (10.09%).
Bal Pharma Financials
Bal Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 69.67 | 69.93 |
| 10 | 69.22 | 69.67 |
| 20 | 69.71 | 70.06 |
| 50 | 71.94 | 72.48 |
| 100 | 77.01 | 77.11 |
| 200 | 87.28 | 84.96 |
Bal Pharma Share Holding Pattern
In the latest quarter, Bal Pharma remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding fell to 0.14%, and public shareholding moved up to 49.01% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Bal Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Feb 03, 2026, 9:21 PM IST | Bal Pharma - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31.12.2025. |
| Jan 09, 2026, 5:49 AM IST | Bal Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 08, 2026, 9:30 PM IST | Bal Pharma Ltd - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
| Nov 13, 2025, 12:27 AM IST | Bal Pharma Ltd - Unaudited Financial Results For The Quarter Ended 30.09.2025 |
| Nov 13, 2025, 12:19 AM IST | Bal Pharma Ltd - Board Meeting Outcome for Outcome Of The Board Meeting_12.11.2025 |
About Bal Pharma
Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 302.50 Cr. and Equity Capital is Rs. 15.92 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address# 21 & 22, Bengaluru Karnataka 560099
- Contact
Management
- Mr. Shailesh D SiroyaManaging Director
- Mr. Himesh VirupakshayaExecutive Director
- Mr. Ravindrakumar KothariNon Executive Director
- Mr. Jatish ShethIndependent Director
- Ms. Nicloa NeeladriIndependent Director
- Mr. H S VenkateshIndependent Director
FAQs on Bal Pharma Share Price
What is the share price of Bal Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bal Pharma is ₹71.34 as on Feb 09, 2026.
What kind of stock is Bal Pharma?
The Bal Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Bal Pharma?
The market cap of Bal Pharma is ₹113.58 Cr as on Feb 09, 2026.
What are today's High and Low prices of Bal Pharma?
Today’s highest and lowest price of Bal Pharma are ₹71.34 and ₹69.55.
What are the 52 Week High and 52 Week Low of Bal Pharma?
The 52-week high/low is the highest and lowest price at which Bal Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bal Pharma is ₹128.86 and 52-week low of Bal Pharma is ₹64.00 as on Feb 09, 2026.
How has the Bal Pharma performed historically in terms of returns?
The Bal Pharma has shown returns of 2.57% over the past day, -3.12% for the past month, -12.87% over 3 months, -35.47% over 1 year, -5.0% across 3 years, and 3.87% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Bal Pharma?
P/E ratio of and PB ratio of Bal Pharma are 16.64 and 1.45 on Feb 09, 2026. While the company gives a dividend yield of 1.68 per annum.
✕
Market Pulse